Consolidative thoracic radiotherapy improves the prognosis of extensive stage small-cell lung cancer patients in the chemoimmunotherapy era: a multicenter retrospective analysis
This study suggests that the addition of cTRT to first-line chemo-immunotherapy significantly improves survival in ES-SCLC with well-tolerated toxicity.
Authors
- Zhaohui Qin (ORCID: https://orcid.org/0000-0001-5883-6239)
- Yuanhu Yao (ORCID: https://orcid.org/0000-0001-7332-600X)
- Shaodong Tong
- Shuai Cheng Li (ORCID: https://orcid.org/0000-0001-6246-6349)
- Nan Zhang (ORCID: https://orcid.org/0000-0002-8309-4262)
- Na Li (ORCID: https://orcid.org/0000-0002-6227-8433)
- Nan Yao (ORCID: https://orcid.org/0009-0001-8191-1855)
- Lingling Hu (ORCID: https://orcid.org/0000-0002-1797-7390)
- Yixian Pei
Institutions
- Jiangnan University (CN)
- Jiangsu University (CN)
- Xuzhou Medical College (CN)
- Ruijin Hospital (CN)
- Xuzhou Cancer Hospital (CN)
- Wuxi Fourth People's Hospital (CN)
- Xuzhou Central Hospital (CN)
- Wuxi People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1080/07853890.2025.2542434
- Citations
- 2
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.09